Design and Discovery of Potent Benzofuran Oxadiazole MAT2A Inhibitors: Synthesis, Structure Activity Relationships, and Molecular Modeling
Pharmaceuticals · 11.11.2026 · 19 (11) · 1789
DOI: 10.3390/ph19111789 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 11.11.2026. Verfasst von Fakhria A. Al-Joufi und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
Background/Objectives: Methionine adenosyltransferase 2A (MAT2A) has emerged as a promising therapeutic target in cancers harboring methylthioadenosine phosphorylase (MTAP) deletion. However, the development of potent, drug-like MAT2A inhibitors with favorable pharmacokinetic profiles remains challenging. This study aimed to design, synthesize, and evaluate a library of benzofuran-based oxadiazole derivatives as novel MAT2A inhibitors and to elucidate their molecular basis of action through integrated computational studies.
Methods
A series of benzofuran-based oxadiazole derivatives (10a–10j and 16–19) was designed, synthesized, and characterized by 1H NMR, 13C NMR, and high-resolution mass spectrometry (HRMS). All compounds were evaluated for MAT2A inhibitory activity, with AZ-28 used as the reference inhibitor. The most active compounds were subjected to molecular docking, 200 ns molecular dynamics (MD) simulations, density functional theory (DFT) calculations, and in silico ADME/toxicity prediction. No preregistration was applicable, and no animals were used in this study.
Results
The synthesized compounds exhibited a broad range of MAT2A inhibition, with IC50 values from 0.0116 ± 0.0020 to 28.77 ± 1.79 μM, benchmarked against AZ-28 (IC50 = 0.0419 ± 0.0032 μM). Compounds 10g (IC50 = 0.0116 ± 0.0020 μM), 10a (IC50 = 0.0883 ± 0.0060 μM), and 19 (IC50 = 0.158 ± 0.015 μM) were the most potent. Docking revealed favorable binding orientations within the MAT2A active site, supported by hydrogen-bonding and hydrophobic interactions. MD simulations showed stable protein–ligand complexes with favorable RMSD profiles, and binding free-energy calculations supported complex stability. DFT analyses (HOMO–LUMO and MEP) provided insight into electronic properties and reactive sites. Furthermore, in silico ADME and toxicity assessments provided preliminary insights into the drug-likeness and pharmacokinetic properties of the studied compounds. Nevertheless, these computational predictions remain preliminary and require experimental validation.
Conclusions
Compounds 10g, 10a, and 19 are promising MAT2A inhibitors, with 10g identified as the most favorable lead. These computational predictions remain preliminary and require experimental validation. Further pharmacokinetic, toxicological, and in vivo studies of 10g are warranted.
Förderung
- Princess Nourah bint Abdulrahman University
Zitieren
APA
Al-Joufi, F. A., Mojally, M., Binsaleh, A. Y., Alwaili, M. A., Alonaizan, R., Alshammari, J. O., Alqahtani, H. A., & Aziz, T. (2026). Design and Discovery of Potent Benzofuran Oxadiazole MAT2A Inhibitors: Synthesis, Structure Activity Relationships, and Molecular Modeling. Pharmaceuticals, 19(11), 1789. https://doi.org/10.3390/ph19111789
Vancouver
Al-Joufi FA, Mojally M, Binsaleh AY, Alwaili MA, Alonaizan R, Alshammari JO, et al. Design and Discovery of Potent Benzofuran Oxadiazole MAT2A Inhibitors: Synthesis, Structure Activity Relationships, and Molecular Modeling. Pharmaceuticals. 2026;19(11):1789. doi:10.3390/ph19111789
BibTeX
@article{AlJoufi2026,
author = {Al-Joufi, Fakhria A. and Mojally, Mariam and Binsaleh, Ammena Y. and Alwaili, Maha Abdullah and Alonaizan, Rasha and Alshammari, Jamilah Obaid and Alqahtani, Huda A. and Aziz, Tariq},
title = {Design and Discovery of Potent Benzofuran Oxadiazole MAT2A Inhibitors: Synthesis, Structure Activity Relationships, and Molecular Modeling},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {11},
pages = {1789},
doi = {10.3390/ph19111789}
}
EUVIMED